38,461 Shares in Nu Skin Enterprises, Inc. $NUS Purchased by Ieq Capital LLC

Key Points

• Ieq Capital LLC has invested approximately $279,000 in Nu Skin Enterprises by acquiring 38,461 shares, representing 0.08% of the company.
• Several institutional investors, including Two Sigma Investments LP and Man Group plc, significantly increased their stakes in Nu Skin Enterprises in the last quarter.
• Nu Skin reported quarterly earnings of $0.43 per share, surpassing estimates and showing a net margin of 6.20%, while also announcing a quarterly dividend of $0.06 per share.

Ieq Capital LLC bought a new stake in shares of Nu Skin Enterprises, Inc. (NYSE:NUS - Free Report) in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 38,461 shares of the company's stock, valued at approximately $279,000. Ieq Capital LLC owned 0.08% of Nu Skin Enterprises at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. GAMMA Investing LLC lifted its position in Nu Skin Enterprises by 102.0% during the first quarter. GAMMA Investing LLC now owns 3,498 shares of the company's stock valued at $25,000 after purchasing an additional 1,766 shares during the period. Public Employees Retirement System of Ohio increased its holdings in Nu Skin Enterprises by 28.5% in the fourth quarter. Public Employees Retirement System of Ohio now owns 7,976 shares of the company's stock valued at $55,000 after buying an additional 1,768 shares in the last quarter. PAX Financial Group LLC increased its holdings in Nu Skin Enterprises by 5.0% in the first quarter. PAX Financial Group LLC now owns 38,473 shares of the company's stock valued at $279,000 after buying an additional 1,840 shares in the last quarter. SummerHaven Investment Management LLC increased its holdings in Nu Skin Enterprises by 2.8% in the first quarter. SummerHaven Investment Management LLC now owns 79,860 shares of the company's stock valued at $580,000 after buying an additional 2,195 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD increased its holdings in Nu Skin Enterprises by 5.3% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 53,711 shares of the company's stock valued at $371,000 after buying an additional 2,702 shares in the last quarter. 82.84% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

NUS has been the subject of a number of recent analyst reports. Zacks Research raised shares of Nu Skin Enterprises to a "hold" rating in a report on Tuesday, August 12th. Wall Street Zen cut shares of Nu Skin Enterprises from a "strong-buy" rating to a "buy" rating in a report on Friday, September 5th. Three investment analysts have rated the stock with a Hold rating, According to MarketBeat, the company has an average rating of "Hold" and an average price target of $6.88.

Insider Transactions at Nu Skin Enterprises

In other news, Director Daniel W. Campbell sold 23,391 shares of the business's stock in a transaction dated Friday, August 29th. The shares were sold at an average price of $12.10, for a total transaction of $283,031.10. Following the completion of the sale, the director owned 53,375 shares of the company's stock, valued at $645,837.50. The trade was a 30.47% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Chayce David Clark sold 20,000 shares of the business's stock in a transaction dated Wednesday, September 3rd. The stock was sold at an average price of $11.97, for a total transaction of $239,400.00. Following the sale, the executive vice president directly owned 233,140 shares of the company's stock, valued at $2,790,685.80. This represents a 7.90% decrease in their position. The disclosure for this sale can be found here. Insiders sold 58,926 shares of company stock valued at $711,364 over the last 90 days. Corporate insiders own 2.00% of the company's stock.

Nu Skin Enterprises Price Performance

Shares of NUS stock traded up $0.35 on Friday, reaching $12.05. 433,951 shares of the company were exchanged, compared to its average volume of 516,533. The company has a market cap of $596.38 million, a price-to-earnings ratio of 5.99 and a beta of 0.92. The business has a 50-day moving average price of $10.25 and a 200 day moving average price of $8.30. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.38 and a current ratio of 2.01. Nu Skin Enterprises, Inc. has a 1 year low of $5.32 and a 1 year high of $12.40.

Nu Skin Enterprises (NYSE:NUS - Get Free Report) last released its earnings results on Thursday, August 7th. The company reported $0.43 EPS for the quarter, topping analysts' consensus estimates of $0.25 by $0.18. The business had revenue of $386.14 million during the quarter, compared to analysts' expectations of $376.68 million. Nu Skin Enterprises had a net margin of 6.20% and a return on equity of 8.23%. Nu Skin Enterprises has set its FY 2025 guidance at 1.150-1.350 EPS. Equities research analysts forecast that Nu Skin Enterprises, Inc. will post 1.05 earnings per share for the current fiscal year.

Nu Skin Enterprises Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, September 10th. Stockholders of record on Friday, August 29th were paid a dividend of $0.06 per share. The ex-dividend date of this dividend was Friday, August 29th. This represents a $0.24 dividend on an annualized basis and a dividend yield of 2.0%. Nu Skin Enterprises's payout ratio is currently 11.94%.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.